IGM Biosciences News

IGM Biosciences | 8-K: Current report

Apr 17 08:39 ET

IGM Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 15 09:04 ET

IGM Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 7 16:32 ET

IGM Biosciences | 8-K: IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 7 16:17 ET

IGM Biosciences | 8-K: Current report

Jan 8 00:00 ET

IGM Biosciences | 8-K: Current report

Dec 8, 2023 16:05 ET

IGM Biosciences | S-3: Registration statement for specified transactions by certain issuers

Nov 13, 2023 17:08 ET

IGM Biosciences | 8-K: IGM Biosciences Announces Third Quarter 2023 Financial Results

Nov 13, 2023 16:10 ET

IGM Biosciences | 8-K: Current report

Oct 3, 2023 16:14 ET

IGM Biosciences | 8-K: IGM Biosciences Announces Second Quarter 2023 Financial Results

Aug 3, 2023 16:13 ET

IGM Biosciences | 8-K: Current report

Jun 27, 2023 17:05 ET

IGM Biosciences | 8-K: Current report

Jun 23, 2023 16:41 ET

IGM Biosciences | 8-K: Current report

Jun 21, 2023 16:59 ET

IGM Biosciences | 8-K: IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update

May 12, 2023 09:06 ET

IGM Biosciences | DEFA14A: Others

Apr 27, 2023 16:32 ET

IGM Biosciences | DEF 14A: Definitive proxy statements

Apr 27, 2023 16:30 ET

IGM Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 30, 2023 16:11 ET

IGM Biosciences | 8-K: IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Mar 30, 2023 16:06 ET

IGM Biosciences | 8-K: Current report

Mar 21, 2023 16:15 ET

IGM Biosciences | 8-K: Current report

Mar 10, 2023 16:22 ET